NovoLet® Acceptance Study Within the Hospital Practise in Indonesia

A Doctor and Nurse Survey on Using NovoLet® Within the Hospital Practice in Indonesia

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01492205

Enrollment

203

Registered

2011-12-14

Start date

2005-09-30

Completion date

2006-06-30

Last updated

2016-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Brief summary

This study is conducted in Asia. The aim of this study is to evaluate the overall acceptance of healthcare professionals (nurses and doctors) to the NovoLet® system used in a hospital environment.

Interventions

DRUGinsulin human

All subjects were treated with human insulin administered either by using the NovoLet® pre-filled insulin system or the conventional vial and syringe method. Doctors and nurses must personally administer at least 10 insulin doses to each patient under their individual clinical supervision for assessment of the NovoLet® pre-filled insulin system

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Type 1 diabetes * Type 2 diabetes * Likely to be hospitalised and require insulin therapy

Design outcomes

Primary

Measure	Time frame
Overall acceptance of the NovoLet® system among healthcare professionals (nurses and doctors)	—

Secondary

Measure	Time frame
Time taken for the healthcare professionals (nurses and doctors) to teach the patient	—
Incidence of adverse drug reactions	—

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026